✦ LIBER ✦

Hepatitis C virus RNA kinetics in chimeric mice with human hepatocytes during antiviral therapy

✍ Scribed by Kazuaki Inoue; Tsunamasa Watanabe; Makoto Yoshiba; Michinori Kohara

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 62 KB
Volume: 46
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.22000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis C virus kinetics in chimeric m

Hepatitis C virus kinetics in chimeric mice during antiviral therapy

✍ Harel Dahari; Alan S. Perelson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 1 views

Our data support the findings of Wieckowska et al. 2 in demonstrating that measuring serum CK-18 fragments level could potentially be used as a noninvasive diagnostic test to predict the severity of NAFLD; however, before the liver biopsy is abandoned altogether, verification of the noninvasive diag

Viral kinetics during antiviral therapy

Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels

✍ Bernd Kronenberger; Eva Herrmann; Florence Micol; Michael von Wagner; Stefan Zeu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

Viral kinetics during antiviral therapy

Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels

✍ Claudio Puoti; Lia Bellis; Roberto Castellacci; Fabrizio Montagnese 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 1 views

We read with interest a paper by Kudo et al. published in a recent issue of HEPATOLOGY that compared the predictive power between Japan Integrated Staging (JIS) system and Cancer of the Liver Italian Program (CLIP) system in a large patient cohort with hepatocellular carcinoma (HCC). 1 The authors c

HCV796: A selective nonstructural protei

HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity In Vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus

✍ Norman M. Kneteman; Anita Y. M. Howe; Tiejun Gao; Jamie Lewis; Dan Pevear; Gary 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

## Anti -hepatitis C virus (HCV) drug development has been challenged by a lack of experience with inhibitors inclusive of in vitro, animal model, and clinical study. This manuscript outlines activity and correlation across such a spectrum of models and into clinical trials with a novel selective

Arthralgias and cryoglobulinemia during

Arthralgias and cryoglobulinemia during protease inhibitor therapy in a patient infected with human immunodeficiency virus and hepatitis C virus

✍ Jean-Jacques Monsuez; Daniel Vittecoq; Lucille Musset; Martine Alemanni; Elisabe 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 2 views

Elevations in alanine aminotransferase l

Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA–negative patients are associated with virological relapse

✍ Monica Basso; Edoardo G. Giannini; Francesco Torre; Sabrina Blanchi; Vincenzo Sa 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 1 views

The incidence and clinical meaning of elevated alanine aminotransferase (ALT) in chronic hepatitis C patients who are hepatitis C virus (HCV)-RNA negative during pegylated interferon (PEG-IFN) and ribavirin therapy have not been completely characterized. In this study our aim was to assess the incid